Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations

Show other versions (1)

Background and aims: Serogroup A, C, W-135 and Y meningococcal (MenACWY) conjugate vaccines are recommended for routine adolescent immunisation in the United States and Canada. We evaluated the persistence of bactericidal antibodies through early childhood, following infant immunisation with varying...

Full description

Bibliographic Details
Main Authors: Khatami, A, Snape, MD, Davis, E, Layton, H, John, T, Yu, L, Dull, P, Gill, C, Odrjlin, T, Dobson, S, Halperin, SA, Langley, J, McNeil, SA, Pollard, A
Format: Journal article
Language:English
Published: 2012

Similar Items